Health News (Reuters)

Toxic particle linked to diesel kills 6,000 a year in Germany: Agency

BERLIN (Reuters) - Some 6,000 early deaths linked to nitrogen oxides (NOx) are recorded each year in Germany, the Federal Environmental Agency said on Thursday, providing more evidence of the health hazards posed by the toxic particles mostly produced by diesel engines.

Roche names Pao as Swiss R&D head after Reed exits

ZURICH (Reuters) - Swiss drugmaker Roche said it will put a cancer specialist at the helm of its Swiss-based research efforts in April, after the scientist who led the unit for five years resigned for personal reasons.

Ukrainian doctor struggles with lack of resources

KIEV (Reuters) - Family doctor Dmitriy Rozumiy struggles to bridge the gap between what his patients in rural Ukraine need and what the country's cash-strapped healthcare system can provide.

Sanofi, Evotec team up for research on infectious diseases treatment

PARIS (Reuters) - Sanofi and Evotec said they had started exclusive talks over accelerating research into the treatment of infectious diseases, and added on Thursday that they would form a new open innovation platform in this area, led by Evotec.

Roche names Pao head of drugs research and early development

ZURICH (Reuters) - Swiss drugmaker Roche named U.S. cancer expert William Pao head of its Pharma Research and Early Development (pRED) business after John Reed decided to leave for what it called personal reasons.

Merck, Eisai in deal to further develop, sell Eisai cancer drug

NEW YORK (Reuters) - Merck & Co Inc and Japan's Eisai Co Ltd on Wednesday announced a potential multibillion-dollar collaboration to develop and sell Eisai's cancer drug Lenvima, which is already approved in dozens of countries for two uses.

Merck, Eisai sign deal to further develop, sell Eisai cancer drug

(Reuters) - Merck & Co Inc and Japan's Eisai Co Ltd on Wednesday announced a potential multibillion-dollar collaboration to develop and sell Eisai's cancer drug Lenvima, which is already approved in dozens of countries for two uses.

FDA's Gottlieb blames industry 'Kabuki drug pricing' for high costs

WASHINGTON (Reuters) - U.S. Food and Drug Administration chief, Scott Gottlieb, criticized pharmacy benefit managers, health insurers and drugmakers on Wednesday for "Kabuki drug-pricing constructs" that profit the industry at the expense of consumers.

FDA receives new reports of issues with Essure birth control device

(Reuters) - The U.S. Food and Drug Administration is investigating new reports of Bayer's implanted birth control device Essure causing problems during removal, the agency said on Wednesday, two years after it slapped a warning label on the product.

U.S. judge says opioid settlement roadblocks may prompt trials

(Reuters) - A federal judge pushing for a settlement in lawsuits by state and local governments against drug companies over their roles in the U.S. opioid epidemic said on Wednesday that trials may be needed after both sides identified barriers to reaching a deal.

Selfies distort the face, plastic surgeons warn

(Reuters Health) - Selfies - or self-photographs - can distort the face and make the nose look larger than it is, according to plastic surgeons who say they’ve seen an uptick in requests for cosmetic procedures from people who want to look better in selfies.

U.S. teens still denied morning-after pill

(Reuters Health) - A new study suggests that some U.S. teens may have trouble getting emergency contraception at pharmacies even though it’s legally available without a prescription for consumers of all ages.

Highly processed foods tied to increased risk of certain cancers

(Reuters Health) - People who consume mostly packaged foods and drinks with lots of unpronounceable ingredients may be more likely to develop certain cancers than people who subsist mostly on whole foods found in nature, a French study suggests.

No risk of new bans on Brazil meat after probe: minister

BRASILIA (Reuters) - Brazil does not face any risks of countries instituting new bans on Brazilian meat imports after the latest phase of the "Weak Flesh" investigation into companies accused of committing fraud to avoid safety checks, Agriculture Minister Blairo Maggi said on Wednesday.

China reports highly pathogenic H5N6, H7N9 bird flu outbreaks: OIE

PARIS (Reuters) - China reported an outbreak of highly pathogenic H5N6 bird flu at a duck farm in the Guangxi province, the Paris-based World Organisation for Animal Health (OIE) said on Wednesday, citing a report from the Chinese agriculture ministry.

Nigeria says 'unprecedented' Lassa fever outbreak killed 110 this year

LAGOS (Reuters) - An outbreak of Lassa fever, a viral hemorrhagic illness, has killed 110 people this year in Nigeria in an "unprecedented" outbreak that has hit half of the states in Africa's most populous nation, its disease control agency said on Wednesday.

Esperion's cholesterol drug succeeds in late-stage study

(Reuters) - Esperion Therapeutics Inc said on Wednesday a late-stage trial of its experimental oral drug met the main goal of reducing cholesterol by 28 percent in patients suffering from, or at a high risk of, an artery-clogging heart disease.